Cancer Prevention Overview (PDQ®): Prevention - Patient Information [NCI] - Interventions That are Known to Lower Cancer Risk
An intervention is a treatment or action taken to prevent or treat disease, or improve health in other ways. Many studies are being done to find ways to keep cancer from starting or recurring (coming back).
Chemoprevention is being studied in patients who have a high risk of developing cancer.
Purpose of This Summary
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about treatment of plasma cell neoplasms (including multiple myeloma). It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.
Reviewers and Updates
This summary is reviewed regularly and updated as necessary...
Chemoprevention is the use of substances to lower the risk of cancer, or keep it from recurring. The substances may be natural or made in the laboratory. Some chemopreventive agents are tested in people who are at high risk for a certain type of cancer. The risk may be because of a precancerous condition, family history, or lifestyle factors.
New ways to prevent cancer are being studied in clinical trials.
Chemoprevention agents that are being studied in clinical trials include COX-2 inhibitors. They are being studied for the prevention of colorectal and breast cancer. Aspirin is being studied for the prevention of colorectal cancer.
See the following PDQ summaries for more information:
Breast Cancer Prevention
Colorectal Cancer Prevention
Clinical trials are taking place in many parts of the country. Check NCI's PDQ Cancer Clinical Trials Registry for cancer prevention trials that are now accepting patients.
See the NCI Web site for more information about cancer prevention.